VSH Stock Analysis: Vishay Intertechnology | NYSE
Semiconductors | NYSE, USA | Market Cap: 6.101m USD | 12M Return: 122.6% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 279M
Qual. Beats: 0
Rev. Trend: -72.0%
Qual. Beats: 3
Warnings
No concerns identified
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Vishay Intertechnology (NYSE: VSH) is a U.S.-headquartered manufacturer of discrete semiconductors and passive electronic components, with operations spanning the United States, Germany, the rest of Europe, Israel, and Asia. The company organizes its business into six product segments: MOSFETs, Diodes, Optoelectronic Components, Resistors, Inductors, and Capacitors. These segments cover a broad portfolio ranging from power transistors and rectifiers to optoelectronic sensors and energy-storage devices used to regulate voltage, current, and signal phases in electronic circuits.
Vishay markets its products under a wide array of established brand names, including Siliconix, Dale, Draloric, Beyschlag, Sprague, Vitramon, and BCcomponents. Its components serve end markets such as automotive, industrial, computing, consumer electronics, telecommunications, military, aerospace, and healthcare. The company was incorporated in 1962 and is headquartered in Malvern, Pennsylvania.
Within the GICS Electronic Components sub-industry, Vishay operates as a broad-line supplier, offering both active (semiconductor) and passive components. This diversified product range allows the company to participate across nearly the entire bill of materials for electronic systems, serving as a key building-block supplier rather than a finished-product manufacturer.
- Automotive electrification lifts MOSFET revenue and capacity utilization
- Industrial destecking pressures resistor and capacitor pricing
- Asia sales concentration exposes earnings to tariff and FX swings
| Net Income: 2.28m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.02 > 0.02 and ΔFCF/TA 3.09 > 1.0 |
| NWC/Revenue: 36.48% < 20% (prev 43.70%; Δ -7.22% < -1%) |
| CFO/TA 0.05 > 3% & CFO 231.9m > Net Income 2.28m |
| Net Debt (740.8m) to EBITDA (311.6m): 2.38 < 3 |
| Current Ratio: 2.64 > 1.5 & < 3 |
| Outstanding Shares: last quarter (137.5m) vs 12m ago 1.23% < -2% |
| Gross Margin: 19.92% > 18% (prev 20.35%; Δ -0.43% > 0.5%) |
| Asset Turnover: 75.46% > 50% (prev 69.20%; Δ 6.26% > 0%) |
| Interest Coverage Ratio: 2.07 > 6 (EBIT TTM 82.4m / Interest Expense TTM 39.8m) |
| A: 0.27 (Total Current Assets 1.88b - Total Current Liabilities 712.2m) / Total Assets 4.26b |
| B: 0.21 (Retained Earnings 885.8m / Total Assets 4.26b) |
| C: 0.02 (EBIT TTM 82.4m / Avg Total Assets 4.23b) |
| D: 0.95 (Book Value of Equity 2.08b / Total Liabilities 2.19b) |
| Altman-Z'' = 3.60 = A |
| DSRI: 0.79 (Receivables 369.2m/427.6m, Revenue 3.19b/2.91b) |
| GMI: 1.02 (GM 20.35% / 19.92%) |
| AQI: 1.02 (AQ_t 0.13 / AQ_t-1 0.13) |
| SGI: 1.10 (Revenue 3.19b / 2.91b) |
| TATA: -0.05 (NI 2.28m - CFO 231.9m) / TA 4.26b) |
| Beneish M = -3.11 (Cap -4..+1) = AA |
As of July 29, 2026, the stock is trading at USD 37.18 with a total of 3,490,192 shares traded. Over the past week, the price has changed by -0.51%, over one month by -33.94%, over three months by +34.11% and over the past year by +122.58%.
Current recommended Stop Loss: 31.00 (which is 16.6% or 1.5 ATR below the current price).
Vishay Intertechnology has received a consensus analysts rating of 3.75. Therefore, it is recommended to hold VSH.
- StrongBuy: 2
- Buy: 0
- Hold: 1
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 34 | -8.6% |
P/E Trailing = 3978.0
P/E Forward = 52.6316
P/S = 1.9108
P/B = 2.7611
P/EG = 1.3478
Revenue TTM = 3.19b USD
EBIT TTM = 82.4m USD
EBITDA TTM = 311.6m USD
Long Term Debt = 983.1m USD (from longTermDebt, last quarter)
Short Term Debt = 26.2m USD (from shortTermDebt, last quarter)
Debt = 1.22b USD (from shortLongTermDebtTotal, last quarter) + Leases 118.6m
Net Debt = 740.8m USD (calculated: Debt 1.22b - CCE 479.5m)
Enterprise Value = 6.84b USD (6.10b + Debt 1.22b - CCE 479.5m)
Interest Coverage Ratio = 2.07 (Ebit TTM 82.4m / Interest Expense TTM 39.8m)
EV/FCF = -75.60x (Enterprise Value 6.84b / FCF TTM -90.5m)
FCF Yield = -1.32% (FCF TTM -90.5m / Enterprise Value 6.84b)
FCF Margin = -2.83% (FCF TTM -90.5m / Revenue TTM 3.19b)
Net Margin = 0.07% (Net Income TTM 2.28m / Revenue TTM 3.19b)
Gross Margin = 19.92% ((Revenue TTM 3.19b - Cost of Revenue TTM 2.56b) / Revenue TTM)
Gross Margin QoQ = 21.04% (prev 19.58%)
Tobins Q-Ratio = 1.61 (Enterprise Value 6.84b / Total Assets 4.26b)
Interest Expense / Debt = 3.26% (Interest Expense 39.8m / Debt 1.22b)
Taxrate = 44.26% (5.69m / 12.9m)
NOPAT = 45.9m (EBIT 82.4m * (1 - 44.26%))
Current Ratio = 2.64 (Total Current Assets 1.88b / Total Current Liabilities 712.2m)
Debt / Equity = 0.59 (Debt 1.22b / totalStockholderEquity, last quarter 2.08b)
Debt / EBITDA = 2.38 (Net Debt 740.8m / EBITDA 311.6m)
Debt / FCF = -8.18 (negative FCF - burning cash) (Net Debt 740.8m / FCF TTM -90.5m)
Total Stockholder Equity = 2.09b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.05% (Net Income 2.28m / Total Assets 4.26b)
RoE = 0.11% (Net Income TTM 2.28m / Total Stockholder Equity 2.09b)
RoCE = 2.69% (EBIT 82.4m / Capital Employed (Equity 2.09b + L.T.Debt 983.1m))
RoIC = 1.34% (NOPAT 45.9m / Invested Capital 3.42b)
WACC = 13.85% (E(6.10b)/V(7.32b) * Re(16.26%) + D(1.22b)/V(7.32b) * Rd(3.26%) * (1-Tc(0.44)))
Discount Rate = 16.26% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: -63.48 | Cagr: -0.57%
[DCF] Fair Price = unknown (Cash Flow -90.5m)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.10 | # QB: 0
Revenue Correlation: -71.98 | Revenue CAGR: -5.42% | SUE: 1.55 | # QB: 3
EPS current Quarter (2026-06-30): EPS=0.14 | Chg30d=+15.87% | Revisions=+0% | Analysts=2
EPS next Quarter (2026-09-30): EPS=0.25 | Chg30d=+28.26% | Revisions=+25% | Analysts=2
EPS current Year (2026-12-31): EPS=0.75 | Chg30d=+46.79% | Revisions=+50% | GrowthEPS=+1607.8% | GrowthRev=+17.5%
EPS next Year (2027-12-31): EPS=1.54 | Chg30d=-0.10% | Revisions=+50% | GrowthEPS=+104.3% | GrowthRev=+12.0%
[Analyst] Revisions Ratio: +58% (up=8, down=1)